|

Gemtuzumab Ozogamicin Clinical Trials

10 actively recruiting trials across 5 locations

Also known as: CDP-771, CMA-676, Calicheamicin-Conjugated Humanized Anti-CD33 Monoclonal Antibody, Mylotarg, WAY-CMA-676, gemtuzumab, hP67.6-Calicheamicin

Houston, Texas3 trials

Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers

M D Anderson Cancer Center

Phase 2
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

M D Anderson Cancer Center

Phase 2
Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia

M D Anderson Cancer Center

Phase 2

Other2 trials

Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML
Phase 3
International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia
Phase 3

Birmingham, Alabama2 trials

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Children's Hospital of Alabama

Phase 3
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

University of Alabama at Birmingham Cancer Center

Phase 2

Phoenix, Arizona1 trial

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Phoenix Children's Hospital

Phase 3

Tampa, Florida1 trial

CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML

Moffitt Cancer Center

Phase 1

Seattle, Washington1 trial

Fractionated Gemtuzumab Ozogamicin in Treating Measurable Residual Disease in Patients With Acute Myeloid Leukemia

Fred Hutchinson Cancer Center/University of Washington Cancer Consortium

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.